⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5961659 | 0.77 | KDM4E (0.51) | — | |
| SCHEMBL7180702 | 0.77 | KDM4E (0.51) | — | |
| SCHEMBL11497872 | 0.76 | INMT (0.52) | — | |
| SCHEMBL3656314 | 0.75 | — | — | |
| SCHEMBL12437181 | 0.75 | — | — | |
| SCHEMBL3656312 | 0.75 | — | — | |
| SCHEMBL6509714 | 0.74 | INMT (0.61) | — | |
| SCHEMBL20083849 | 0.73 | INMT (0.48) | — | |
| SCHEMBL3606378 | 0.70 | — | — | |
| SCHEMBL10969327 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8648087-B2 | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | ARRAY BIOPHARMA, INC. (US) | 2014-02-11 | — | — | US | disclosed |
| US-20110034689-A1 | N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as ErbB Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases | ARRAY BIOPHARMA, INC. | 2011-02-10 | — | — | US | disclosed |